# Screening for Systemic Amyloidosis Via the Ligamentum Flavum

> **NCT03923920** · — · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 200 (actual)

## Conditions studied

- Amyloid
- Amyloidosis
- Spinal Stenosis
- Transthyretin Amyloidosis
- Primary Amyloidosis of Light Chain Type

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT03923920
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2021-10-04
- **Final completion:** 2021-12-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03923920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03923920, "Screening for Systemic Amyloidosis Via the Ligamentum Flavum". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03923920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*